These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23466625

  • 1. Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
    Nerreter T, Distler E, Köchel C, Einsele H, Herr W, Seggewiss-Bernhardt R.
    Exp Hematol; 2013 Jul; 41(7):604-614.e4. PubMed ID: 23466625
    [Abstract] [Full Text] [Related]

  • 2. Profound inhibition of antigen-specific T-cell effector functions by dasatinib.
    Weichsel R, Dix C, Wooldridge L, Clement M, Fenton-May A, Sewell AK, Zezula J, Greiner E, Gostick E, Price DA, Einsele H, Seggewiss R.
    Clin Cancer Res; 2008 Apr 15; 14(8):2484-91. PubMed ID: 18413841
    [Abstract] [Full Text] [Related]

  • 3. Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens.
    Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Greiner J, Götz M, Guillaume P, Döhner H, Bunjes D, Schmitt M.
    Exp Hematol; 2008 Oct 15; 36(10):1297-308. PubMed ID: 18619726
    [Abstract] [Full Text] [Related]

  • 4. Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo.
    Fraser CK, Blake SJ, Diener KR, Lyons AB, Brown MP, Hughes TP, Hayball JD.
    Exp Hematol; 2009 Feb 15; 37(2):256-65. PubMed ID: 19056158
    [Abstract] [Full Text] [Related]

  • 5. Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.
    Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Götz M, Döhner H, Bunjes D, Schmitt M.
    Br J Haematol; 2009 Jan 15; 144(2):195-205. PubMed ID: 19016717
    [Abstract] [Full Text] [Related]

  • 6. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM, van Luxemburg-Heijs SA, Rijnbeek M, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 1996 Feb 15; 2(1):31-6. PubMed ID: 9078352
    [Abstract] [Full Text] [Related]

  • 7. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.
    Uchiyama T, Sato N, Narita M, Yamahira A, Iwabuchi M, Furukawa T, Sone H, Takahashi M.
    Hematol Oncol; 2013 Sep 15; 31(3):156-63. PubMed ID: 23108877
    [Abstract] [Full Text] [Related]

  • 8. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Vallera DA.
    J Immunol; 1998 Jun 01; 160(11):5355-65. PubMed ID: 9605135
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib.
    Hassold N, Seystahl K, Kempf K, Urlaub D, Zekl M, Einsele H, Watzl C, Wischhusen J, Seggewiss-Bernhardt R.
    Int J Cancer; 2012 Sep 15; 131(6):E916-27. PubMed ID: 22419518
    [Abstract] [Full Text] [Related]

  • 10. The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro.
    Blake S, Hughes TP, Mayrhofer G, Lyons AB.
    Clin Immunol; 2008 Jun 15; 127(3):330-9. PubMed ID: 18395492
    [Abstract] [Full Text] [Related]

  • 11. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
    Fiskus W, Pranpat M, Balasis M, Bali P, Estrella V, Kumaraswamy S, Rao R, Rocha K, Herger B, Lee F, Richon V, Bhalla K.
    Clin Cancer Res; 2006 Oct 01; 12(19):5869-78. PubMed ID: 17020995
    [Abstract] [Full Text] [Related]

  • 12. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ, Ritz J.
    Clin Cancer Res; 2002 Jul 01; 8(7):2052-60. PubMed ID: 12114403
    [Abstract] [Full Text] [Related]

  • 13. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
    Wijesundara DK, Kumar S, Alsharifi M, Müllbacher A, Regner M.
    Int Immunol; 2010 Sep 01; 22(9):757-67. PubMed ID: 20682547
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations.
    Bass HZ, Yamashita N, Clement LT.
    J Immunol; 1993 Sep 15; 151(6):2895-903. PubMed ID: 8376760
    [Abstract] [Full Text] [Related]

  • 15. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ, Norihisa Y, Ortaldo JR.
    J Immunol; 1992 Jan 01; 148(1):55-62. PubMed ID: 1345790
    [Abstract] [Full Text] [Related]

  • 16. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
    Milner JD, Kent SC, Ashley TA, Wilson SB, Strominger JL, Hafler DA.
    J Immunol; 1999 Sep 01; 163(5):2522-9. PubMed ID: 10452989
    [Abstract] [Full Text] [Related]

  • 17. Human atopen-specific types 1 and 2 T helper cell clones.
    Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RA, Kapsenberg ML.
    J Immunol; 1991 Nov 01; 147(9):2942-9. PubMed ID: 1680923
    [Abstract] [Full Text] [Related]

  • 18. Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.
    Li D, Li Y, Hernandez JA, Patenia R, Kim TK, Khalili J, Dougherty MC, Hanley PJ, Bollard CM, Komanduri KV, Hwu P, Champlin RE, Radvanyi LG, Molldrem JJ, Ma Q.
    J Immunother; 2010 Nov 01; 33(9):975-82. PubMed ID: 20948439
    [Abstract] [Full Text] [Related]

  • 19. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ, Falkenburg JH, Fibbe WE, Veenhof WF, Hamilton M, Van Krimpen BA, Bolhuis RL.
    J Immunol; 1989 Mar 01; 142(5):1774-80. PubMed ID: 2521886
    [Abstract] [Full Text] [Related]

  • 20. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
    Tawfik DS, Cowan KR, Walsh AM, Hamilton WS, Goldman FD.
    Pediatr Allergy Immunol; 2012 Feb 01; 23(1):88-95. PubMed ID: 21265884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.